Sharpe ratio is not yet available for LIPO. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar stocks
The table compares Lipella Pharmaceuticals Inc.'s Sharpe Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how LIPO's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 24, 2026.
| Symbol | Name | 1Y Sharpe Ratio | 5Y Sharpe Ratio | 10Y Sharpe Ratio | All Time Sharpe Ratio |
|---|---|---|---|---|---|
| RVMDW | Revolution Medicines Inc. Warrant | 12.97 | |||
| ERAS | Erasca, Inc. | 9.52 | |||
| CLYM | Climb Bio Inc | 9.44 | |||
| ORKA | Oruka Therapeutics, Inc | 8.70 | |||
| SLGL | Sol-Gel Technologies Ltd. | 8.55 | |||
| RLMD | Relmada Therapeutics, Inc. | 8.34 | |||
| SYRE | Spyre Therapeutics Inc. | 8.24 | |||
| ANRO | Alto Neuroscience, Inc | 7.25 | |||
| LQDA | Liquidia Corporation | 6.98 | |||
| KOD | Kodiak Sciences Inc. | 6.84 | |||
| LIPO | Lipella Pharmaceuticals Inc. | — |
Loading charts...
Sharpe Ratio Calculator
How does LIPO fit in your portfolio?
Add your other holdings to see your portfolio's Sharpe Ratio and find out.
Analyze Your Portfolio